Ameriprise’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9M | Buy |
663,096
+40,646
| +7% | +$994K | ﹤0.01% | 1580 |
|
|
2025
Q4 | $14.1M | Sell |
622,450
-5,128
| -0.8% | -$112K | ﹤0.01% | 1661 |
|
|
2025
Q3 | $12.6M | Buy |
627,578
+437,958
| +231% | +$7.34M | ﹤0.01% | 1729 |
|
|
2025
Q2 | $2.71M | Buy |
189,620
+51,123
| +37% | +$598K | ﹤0.01% | 2779 |
|
|
2025
Q1 | $1.45M | Buy |
138,497
+41,124
| +42% | +$465K | ﹤0.01% | 3054 |
|
|
2024
Q4 | $1.18M | Buy |
97,373
+54,581
| +128% | +$714K | ﹤0.01% | 3173 |
|
|
2024
Q3 | $629K | Sell |
42,792
-725,494
| -94% | -$10.1M | ﹤0.01% | 3406 |
|
|
2024
Q2 | $11.1M | Sell |
768,286
-155,080
| -17% | -$2.48M | ﹤0.01% | 1659 |
|
|
2024
Q1 | $15M | Buy |
923,366
+13,009
| +1% | +$203K | ﹤0.01% | 1485 |
|
|
2023
Q4 | $13.6M | Sell |
910,357
-14,497
| -2% | -$164K | ﹤0.01% | 1528 |
|
|
2023
Q3 | $10.4M | Buy |
924,854
+47,325
| +5% | +$550K | ﹤0.01% | 1679 |
|
|
2023
Q2 | $8.83M | Sell |
877,529
-166,081
| -16% | -$1.54M | ﹤0.01% | 1880 |
|
|
2023
Q1 | $9.81M | Sell |
1,043,610
-1,321
| -0.1% | -$15.6K | ﹤0.01% | 1791 |
|
|
2022
Q4 | $12.8M | Buy |
1,044,931
+84,178
| +9% | +$1.05M | ﹤0.01% | 1542 |
|
|
2022
Q3 | $11.9M | Buy |
960,753
+335,408
| +54% | +$5.86M | ﹤0.01% | 1529 |
|
|
2022
Q2 | $12.3M | Buy |
625,345
+47,374
| +8% | +$1.12M | ﹤0.01% | 1568 |
|
|
2022
Q1 | $15.1M | Sell |
577,971
-189,307
| -25% | -$5.04M | ﹤0.01% | 1572 |
|
|
2021
Q4 | $21.7M | Sell |
767,278
-2,058,422
| -73% | -$64M | 0.01% | 1336 |
|
|
2021
Q3 | $90.1M | Sell |
2,825,700
-433,553
| -13% | -$14.5M | 0.03% | 550 |
|
|
2021
Q2 | $116M | Buy |
3,259,253
+296,323
| +10% | +$9.77M | 0.04% | 481 |
|
|
2021
Q1 | $86.3M | Buy |
2,962,930
+157,766
| +6% | +$4.85M | 0.03% | 564 |
|
|
2020
Q4 | $85.9M | Buy |
2,805,164
+889,777
| +46% | +$27.1M | 0.03% | 524 |
|
|
2020
Q3 | $53.4M | Buy |
1,915,387
+1,148,235
| +150% | +$29.1M | 0.02% | 610 |
|
|
2020
Q2 | $16.5M | Sell |
767,152
-53,238
| -6% | -$1.18M | 0.01% | 1181 |
|
|
2020
Q1 | $18.4M | Buy |
820,390
+740,381
| +925% | +$20.3M | 0.01% | 986 |
|
|
2019
Q4 | $2.36M | Sell |
80,009
-1,273,954
| -94% | -$34.6M | ﹤0.01% | 2648 |
|
|
2019
Q3 | $36M | Sell |
1,353,963
-503,830
| -27% | -$15.1M | 0.02% | 811 |
|
|
2019
Q2 | $62.8M | Buy |
1,857,793
+70,192
| +4% | +$2.28M | 0.03% | 570 |
|
|
2019
Q1 | $57.3M | Buy |
1,787,601
+218,801
| +14% | +$6.73M | 0.03% | 594 |
|
|
2018
Q4 | $49.5M | Sell |
1,568,800
-66,500
| -4% | -$2.18M | 0.02% | 628 |
|
|
2018
Q3 | $57M | Buy |
+1,635,300
| New | +$57.5M | 0.02% | 690 |
|
Other funds holding ELAN
VPM
VCM
Ameriprise's ELAN Position: Q1 2026 in Review
Ameriprise increased its Elanco Animal Health (ELAN) stake by 6.5% in Q1 2026, buying an estimated $994K and bringing the position to 663,096 shares worth $15.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1580.
Ameriprise first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $116M in Q2 2021. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Ameriprise held 663,096 shares of Elanco Animal Health worth $15.9M as of Q1 2026.
- Ameriprise bought 40,646 Elanco Animal Health shares in Q1 2026, an estimated $994K.
- Elanco Animal Health made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1580 holding.
- Ameriprise first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
- Ameriprise's Elanco Animal Health position peaked at $116M in Q2 2021.
- 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.